GLOW BLEND 10 + 50 + 10MG

GLOW is a trade name for a lyophilised blend of three research peptides in one vial: BPC-157, GHK-Cu and TB-500. The supplier labels the vial as BPC-157 10 mg, GHK-Cu 50 mg and TB-500 10 mg. It is a physical mixture, not a new compound, so it has no CAS number or PubChem record of its own: each component keeps its own identity, listed below.¹

Titan Peptides supplies the blend as a lyophilised powder in a sealed vial, for laboratory and research use only. It is a research chemical: not a drug, food or cosmetic, and not for human consumption.

In the Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, which commenced on 1 June 2026, BPC-157 is listed in Schedule 4 (prescription-only medicines) and in Appendix D, clause 5, the table of poisons that "must not be possessed by a person without authority". TB-500 and thymosin beta 4 each have their own entry in Schedule 4 and are also listed in Appendix D, clause 5.² The TGA's 13 April 2026 safety advisory names BPC-157, TB-500 and GHK-Cu as examples of unapproved peptide products and states that a "research use only" disclaimer does not make supply lawful.³

A blend containing them is not an approved therapeutic good in Australia; the vial sold here is a research chemical. Our guide to research peptides and Australian law explains how scheduling applies.

Keep the sealed vial dry, dark and frozen at −20 °C or colder, and let it reach room temperature in a desiccator before opening. A blend is only as stable as its least stable component: TB-500's C-terminal glutamine can deamidate in solution, and the copper complex changes species with pH. Because three peptides share one solution, choose a solvent compatible with all of them, free of chelators such as EDTA that would strip copper from GHK-Cu. Keep any reconstituted stock as frozen single-use aliquots and do not refreeze a thawed aliquot. See how to store peptides and reconstituting peptides.